Systemic amyloidosis
Conditions
Interventions
None listed
Sponsors
University of Fukui
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients with pathologically proven amyloid deposition in organs 2) Patients diagnosed with systemic amyloidosis by immunohistochemical testing of biopsy tissue using specific antibodies (AA, ALkappa, ALlambda, ATTR, Abeta2M) 3) Patients who have not undergone 1) or 2) above, but have been diagnosed with ATTRwt amyloidosis based on myocardial uptake in 99mTc bone scintigraphy 4) Patients who have given written consent to participate in the study
Exclusion criteria
Exclusion criteria: Patients who are judged by researchers to be inappropriate as study subjects
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Accumulation of clinical information and genomic data on systemic amyloidosis | — |
Countries
Japan
Contacts
Public ContactJin Endo
Keio University Department of Cardiology
Outcome results
None listed